Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Diabetes and Endocrinology
GLP-1 Receptor Agonists Have Better Outcomes Than DPP4 Inhibitors In T2D Patients & CKD
0 Comments
Post a comment
No comments yet. Be the first to comment!